Cargando…

Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is one of the most common hereditary heart diseases and is associated with a high risk of sudden cardiac death. HCM is characterized by pronounced hypertrophy of cardiomyocytes, fiber disarray and development of fibrosis and can be divided into a non-obstructive (HN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sonnenschein, Kristina, Wilczek, Adriana Luisa, de Gonzalo-Calvo, David, Pfanne, Angelika, Derda, Anselm Arthur, Zwadlo, Carolin, Bavendiek, Udo, Bauersachs, Johann, Fiedler, Jan, Thum, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937321/ https://www.ncbi.nlm.nih.gov/pubmed/31889077 http://dx.doi.org/10.1038/s41598-019-56617-2

Ejemplares similares

Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy
por: Sonnenschein, Kristina, et al.
Publicado: (2021)

Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity
por: Chatterjee, Shambhabi, et al.
Publicado: (2018)

Therapeutic modulation of RNA-binding protein Rbm38 facilitates re-endothelialization after arterial injury
por: Sonnenschein, Kristina, et al.
Publicado: (2019)

Blood-based microRNA profiling in patients with cardiac amyloidosis
por: Derda, Anselm A., et al.
Publicado: (2018)

Anti-androgenic therapy with finasteride in patients with chronic heart failure - a retrospective propensity score based analysis
por: Kattih, Badder, et al.
Publicado: (2019)

Circulating fibroblast activation protein α is reduced in acute ischemic stroke
por: Sieweke, Jan-Thorben, et al.
Publicado: (2022)

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
por: Sieweke, Jan-Thorben, et al.
Publicado: (2020)

Echocardiographic Parameters to Predict Atrial Fibrillation in Clinical Routine—The EAHsy-AF Risk Score
por: Sieweke, Jan-Thorben, et al.
Publicado: (2022)

Circulating cardiovascular microRNAs in critically ill COVID‐19 patients
por: Garg, Ankita, et al.
Publicado: (2021)

Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure
por: Bavendiek, Udo, et al.
Publicado: (2017)

Artificial Intelligence Identifies an Urgent Need for Peripheral Vascular Intervention by Multiplexing Standard Clinical Parameters
por: Sonnenschein, Kristina, et al.
Publicado: (2021)

Digoxin–mortality: randomized vs. observational comparison in the DIG trial
por: Aguirre Dávila, Lukas, et al.
Publicado: (2019)

MicroRNAs bei COVID-19: kleine Moleküle mit großem Potenzial?
por: Bär, Christian, et al.
Publicado: (2021)

Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2022)

Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla(®) Flex II Occluder
por: Neuser, Jonas, et al.
Publicado: (2016)

Reply to ‘COVID‐19 severity, miR‐21 targets, and common human genetic variation’
por: Derda, Anselm A., et al.
Publicado: (2021)

MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart
por: Jazbutyte, Virginija, et al.
Publicado: (2012)

Postinfarction posterior ventricular septal rupture mimicking a biventricular free wall rupture with extracardiac left-to-right shunt
por: Badder, Kattih, et al.
Publicado: (2015)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

The systolic paradox in hypertrophic cardiomyopathy
por: Haland, Trine F, et al.
Publicado: (2017)

Cardiomyopathies—past, present, future
por: Maisch, Bernhard, et al.
Publicado: (2020)

Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
por: Stojanović, Stevan D, et al.
Publicado: (2020)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Of mice and men: models and mechanisms of diabetic cardiomyopathy
por: Riehle, Christian, et al.
Publicado: (2018)

C1q and Tumor Necrosis Factor Related Protein 9 Protects from Diabetic Cardiomyopathy by Alleviating Cardiac Insulin Resistance and Inflammation
por: Haustein, Ricarda, et al.
Publicado: (2023)

Giant cell myocarditis after first dose of BNT162b2 – a case report
por: Hirsch, Valentin G., et al.
Publicado: (2022)

Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction
por: Haghikia, Arash, et al.
Publicado: (2018)

Neonatal injury models: integral tools to decipher the molecular basis of cardiac regeneration
por: Costa, Alessia, et al.
Publicado: (2022)

Right Ventricular Function Improves Early After Percutaneous Mitral Valve Repair in Patients Suffering From Severe Mitral Regurgitation
por: Neuser, Jonas, et al.
Publicado: (2022)

Comprehensive Construction of a Circular RNA-Associated Competing Endogenous RNA Network Identified Novel Circular RNAs in Hypertrophic Cardiomyopathy by Integrated Analysis
por: Guo, Qi, et al.
Publicado: (2020)

An Unusual Type of Hypertrophic Cardiomyopathy
por: Seo, Hye-Sun, et al.
Publicado: (2009)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: A Review
por: Houston, Brian A, et al.
Publicado: (2015)

Aortic biomechanics in hypertrophic cardiomyopathy
por: Badran, Hala Mahfouz, et al.
Publicado: (2015)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2qsh0qk9309b7gb418fnqotu6o